로딩 중…
지수 로딩 중…
SG HealthCare Co., Ltd.
398120· KOSDAQ· Health Care· Health Care Equipment & Services
₩1,942+1.78%
2026-08-04
Financials
Valuation Metrics
SG HealthCare Co., Ltd.'s Market Cap is ₩230B. At end of 2025 it was ₩355B. Ranked #2236 of 2,436 in KR market (top 92%), #1465 of 1,649 on KOSDAQ (top 89%), #92 of 96 in Health Care Equipment & Services (top 96%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 23.00B KRW | KR#2,236/2,436 Sec#92/96 |
| Revenue | 25.88B KRW | KR#2,073/2,436 Sec#69/96 |
| Net Income | 1.36B KRW | KR#1,405/2,436 Sec#45/96 |
| Total Assets | 39.19B KRW | KR#2,275/2,436 Sec#82/96 |
| Net Assets | 25.90B KRW | KR#2,207/2,436 Sec#81/96 |
| Employees | 35 | KR#2,145/2,436 Sec#82/96 |
| Value | ||
| P/E | 16.88x | KR#1,035/2,436 Sec#31/96 |
| P/B | 0.89x | KR#1,382/2,436 Sec#30/96 |
| P/S | 0.89x | KR#1,303/2,436 Sec#23/96 |
| EV/EBITDA | 13.92x | KR#815/2,436 Sec#23/96 |
| Profitability | ||
| ROE | 5.26% | KR#966/2,436 Sec#33/96 |
| ROA | 3.48% | KR#874/2,436 Sec#35/96 |
| Op. Margin | 7.42% | KR#670/2,436 Sec#34/96 |
| Revenue Growth | 34.87% | KR#422/2,436 Sec#17/96 |
| Financial Health | ||
| Debt Ratio | 151.31% | KR#1,206/2,436 Sec#64/96 |
| Total Debt | 7.47B KRW | KR#1,709/2,436 Sec#57/96 |
| Cash | 3.75B KRW | KR#2,090/2,436 Sec#81/96 |
| Current Ratio | 2.03x | KR#935/2,436 Sec#50/96 |
| Net Debt/EBITDA | 1.94x | KR#885/2,436 Sec#36/96 |
| Performance | ||
| 1Y Return | -37.46% | KR#1,775/2,436 Sec#60/96 |
| 1M Return | -7.52% | KR#1,592/2,436 Sec#66/96 |
| From 52W High | -60.73% | KR#1,746/2,436 Sec#62/96 |
| 1Y MDD | -59.07% | KR#1,353/2,436 Sec#47/96 |
| Trading | ||
| Volume | 55,162 shares | KR#1,277/2,436 Sec#56/96 |
| Foreign Own. | 5.74% | KR—/2,436 Sec—/96 |
| Per Share | ||
| EPS | 120 KRW | KR#1,325/2,436 Sec#43/96 |
| BPS | 2,215 KRW | KR#1,977/2,436 Sec#63/96 |
Company Info
SG Healthcare, established in 2009, specializes in the manufacturing and sales of medical imaging diagnostic devices, listing on KOSDAQ in 2024. The company produces X-ray, C-arm, CT/MRI, and ultrasound equipment. In 2021, it established a subsidiary to develop AI software, receiving approval in 2022. SG Healthcare is expanding R&D investments in medical imaging diagnostic devices and AI software, growing into a specialized medical device company headquartered in Icheon-si, Gyeonggi-do.